Quaker Chemical Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de Quaker Chemical han disminuido a una tasa media anual de -24.6%, mientras que en la industria Chemicals los beneficios crecieron en un 3.7% anualmente. Los ingresos han ido creciendo a una tasa media de 2.3% al año. La rentabilidad financiera de Quaker Chemical es de 0.3%, y sus márgenes netos son de 0.2%.
Información clave
-24.56%
Tasa de crecimiento de los beneficios
-24.69%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 12.93% |
| Tasa de crecimiento de los ingresos | 2.34% |
| Rentabilidad financiera | 0.32% |
| Margen neto | 0.22% |
| Última actualización de beneficios | 31 Mar 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
KWR: Market Share Gains And M&A Activity Will Support Future P/E Premium
Analysts have trimmed their average price target for Quaker Chemical to about $184 from roughly $203 as they factor in softer revenue growth assumptions, a lower future P/E, and updated views from recent research that cites more moderate sales and EBITDA expectations despite ongoing share gains in subdued end markets. Analyst Commentary Recent research on Quaker Houghton has been mixed, but several bullish analysts still see room for upside based on execution, valuation, and the company’s ability to grow share even in softer end markets.
KWR: M&A Execution And Share Gains Will Support Future Upside
Narrative Update: Quaker Chemical Analyst Price Target Shift Analysts now center their price target for Quaker Chemical around $183, reflecting a blend of Seaport's downgrade, Deutsche Bank's lift to $170, and RBC Capital's reset to $184 after Q4 results and softer 2026 guidance, while still acknowledging ongoing share gains in flat to slightly weaker end markets. Analyst Commentary Recent research on Quaker Chemical highlights a split view on how the story stacks up after Q4 results and updated guidance, with price targets clustering in the mid to high $100s.KWR: Market Share Gains And M&A Focus Will Support Premium P/E Multiple
Quaker Chemical's updated analyst price target has moved from $190 to $203, with analysts pointing to revised assumptions on revenue growth, profit margins, and a higher future P/E multiple, informed by recent target changes at firms covering Quaker Houghton. Analyst Commentary Recent research on Quaker Chemical, which operates as Quaker Houghton, reflects a mix of higher and lower price targets and at least one ratings downgrade, giving you a range of views on how the company is executing and how the stock is valued today.KWR: Higher Earnings Multiple And M&A Activity Will Support Future Upside
Analysts have lifted their blended price target for Quaker Houghton to about $183, up from roughly $172, as they weigh softer guidance and margin assumptions against continued share gains and updated P/E expectations reflected in recent research moves. Analyst Commentary Recent research on Quaker Houghton reflects a mix of optimism and caution, with price targets being fine tuned around updated growth, margin and P/E expectations following the latest earnings and guidance.KWR: Updated Assumptions And Mixed Ratings Will Shape Balanced Future Expectations
Analysts have raised their price target on Quaker Chemical to $172.25 from $166. This change reflects updated views on fair value, a slightly lower discount rate, modest adjustments to long-term revenue and margin assumptions, and a somewhat higher assumed future P/E multiple.KWR: Higher Margin Assumptions Will Reframe Earnings Risk Ahead Of Results
Analysts have raised their fair value estimate for Quaker Chemical to $190 from $165, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E levels in recent research. Analyst Commentary Recent Street research on Quaker Chemical points to a mixed but increasingly engaged analyst view, with some firms revisiting their assumptions around earnings and valuation ahead of upcoming results.KWR: Completed Buybacks And Steady Assumptions Will Shape Balanced Future Prospects
Analysts have reaffirmed their view on Quaker Chemical, keeping the fair value estimate steady at $166.00 as small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions did not materially shift their overall price target framework. What's in the News From July 1, 2025 to September 30, 2025, Quaker Chemical repurchased 29,791 shares for $3.81 million, representing 0.17% of its shares.These 4 Measures Indicate That Quaker Chemical (NYSE:KWR) Is Using Debt Reasonably Well
Jan 11
KWR: Share Repurchases And Stable Assumptions Will Support Future Upside Potential
Analysts kept their price target for Quaker Chemical steady at $166, reflecting only small model tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a change in their overall view of the shares. What's in the News From July 1, 2025 to September 30, 2025, Quaker Chemical repurchased 29,791 shares for $3.81 million, representing 0.17% of its shares.KWR: Ongoing Share Repurchases Will Likely Support Strong Future Share Performance
Narrative Update Analysts have raised their price target on Quaker Chemical by $0.00 to account for slightly lower discount rate assumptions and modest adjustments to long-term growth and profitability forecasts. What's in the News Completed share repurchase of 638,901 shares, about 3.59% of outstanding shares, for a total of $85.75 million under the buyback program announced on February 28, 2024 (company filing) Between July 1, 2025 and September 30, 2025, repurchased 29,791 shares, representing 0.17% of shares, for $3.81 million as the final tranche of the current authorization (company filing) Ongoing capital return via buybacks signals management confidence in long term cash generation and balance sheet strength (company filing) Valuation Changes Fair Value: unchanged at $166.00 per share, reflecting no net impact from the updated assumptions.There's Been No Shortage Of Growth Recently For Quaker Chemical's (NYSE:KWR) Returns On Capital
Dec 19KWR: Ongoing Share Repurchases Will Likely Support Strong Future Share Performance
Narrative Update on Quaker Chemical Analysts have maintained their price target for Quaker Chemical at approximately 166 dollars, as modest adjustments to the discount rate and long term growth assumptions were not deemed sufficient to warrant a change in fair value. What's in the News The company completed its share repurchase program announced on February 28, 2024, buying back a total of 638,901 shares, or about 3.59% of shares outstanding, for approximately 85.75 million dollars (company filing).KWR: Share Repurchases Are Expected To Drive Positive Market Reactions
Narrative Update on Quaker Chemical Analysts have raised their price target for Quaker Chemical from $162 to $166, reflecting a modest increase based on updated assessments of company valuation metrics and market outlook. What's in the News Between July 1, 2025 and September 30, 2025, Quaker Chemical repurchased 29,791 shares for $3.81 million, representing 0.17 percent of its outstanding shares (Key Developments).KWR: Expanding Share Buybacks Will Drive Stronger Profit Margins Ahead
Analysts have raised their price target for Quaker Chemical from $155.40 to $162.00. They cite improved profit margin forecasts and higher projected revenue growth as key factors in the revised valuation.Quaker Chemical: The Worst Should Be Behind Us Now
Oct 08Quaker Chemical's (NYSE:KWR) Upcoming Dividend Will Be Larger Than Last Year's
Oct 02Is There An Opportunity With Quaker Chemical Corporation's (NYSE:KWR) 48% Undervaluation?
Sep 24Quaker Chemical Corporation's (NYSE:KWR) 26% Price Boost Is Out Of Tune With Revenues
Aug 30Sustainable Chemistries And Asia Expansion Will Empower Manufacturing Automation
The upward revision in Quaker Chemical’s consensus price target reflects a minor increase in forecasted future P/E ratio, while valuation inputs like the discount rate remain stable, resulting in a fair value target rising to $155.40. What's in the News Reported an $88.8 million goodwill impairment charge related to the EMEA segment, resulting in a quarterly net loss.Is Now An Opportune Moment To Examine Quaker Chemical Corporation (NYSE:KWR)?
May 28Quaker Chemical Corporation (NYSE:KWR) Shares Could Be 49% Below Their Intrinsic Value Estimate
Apr 25Risks Still Elevated At These Prices As Quaker Chemical Corporation (NYSE:KWR) Shares Dive 27%
Apr 08Quaker Chemical: Starting To Look More Attractive
Mar 26We Like These Underlying Return On Capital Trends At Quaker Chemical (NYSE:KWR)
Feb 03Does Quaker Chemical (NYSE:KWR) Have A Healthy Balance Sheet?
Jan 19Quaker Chemical Corporation's (NYSE:KWR) Earnings Haven't Escaped The Attention Of Investors
Jan 03Is There An Opportunity With Quaker Chemical Corporation's (NYSE:KWR) 46% Undervaluation?
Dec 15Quaker Chemical (NYSE:KWR) Shareholders Will Want The ROCE Trajectory To Continue
Nov 02Why Quaker Chemical Corporation (NYSE:KWR) Could Be Worth Watching
Oct 17Is Quaker Chemical (NYSE:KWR) A Risky Investment?
Sep 20A Look At The Fair Value Of Quaker Chemical Corporation (NYSE:KWR)
Sep 06
Houghton's Decisive Expansion And Innovation Drive Long-Term Growth And Market Dominance
Expanding business in Asia Pacific and operational efficiencies are poised to significantly augment revenue growth and improve net margins.Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Quaker Chemical. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 1,926 | 4 | 385 | 61 |
| 31 Dec 25 | 1,889 | -2 | 368 | 61 |
| 30 Sep 25 | 1,864 | -9 | 380 | 57 |
| 30 Jun 25 | 1,833 | -7 | 372 | 57 |
| 31 Mar 25 | 1,813 | 94 | 366 | 57 |
| 31 Dec 24 | 1,840 | 116 | 369 | 57 |
| 30 Sep 24 | 1,863 | 122 | 377 | 50 |
| 30 Jun 24 | 1,891 | 123 | 381 | 50 |
| 31 Mar 24 | 1,923 | 118 | 382 | 50 |
| 31 Dec 23 | 1,953 | 112 | 377 | 50 |
| 30 Sep 23 | 1,971 | 16 | 369 | 46 |
| 30 Jun 23 | 1,973 | 9 | 368 | 46 |
| 31 Mar 23 | 1,970 | -6 | 359 | 46 |
| 31 Dec 22 | 1,944 | -16 | 359 | 46 |
| 30 Sep 22 | 1,906 | 78 | 338 | 45 |
| 30 Jun 22 | 1,863 | 83 | 321 | 45 |
| 31 Mar 22 | 1,806 | 102 | 320 | 45 |
| 31 Dec 21 | 1,761 | 121 | 313 | 45 |
| 30 Sep 21 | 1,700 | 151 | 318 | 40 |
| 30 Jun 21 | 1,618 | 147 | 310 | 40 |
| 31 Mar 21 | 1,469 | 106 | 311 | 40 |
| 31 Dec 20 | 1,418 | 40 | 306 | 40 |
| 30 Sep 20 | 1,423 | 6 | 348 | 32 |
| 30 Jun 20 | 1,381 | -34 | 333 | 32 |
| 31 Mar 20 | 1,301 | -11 | 275 | 32 |
| 31 Dec 19 | 1,134 | 32 | 227 | 32 |
| 30 Sep 19 | 954 | 24 | 204 | 25 |
| 30 Jun 19 | 851 | 57 | 176 | 25 |
| 31 Mar 19 | 867 | 60 | 180 | 25 |
| 31 Dec 18 | 868 | 59 | 178 | 25 |
| 30 Sep 18 | 867 | 42 | 210 | 0 |
| 30 Jun 18 | 858 | 33 | 208 | 0 |
| 31 Mar 18 | 837 | 26 | 205 | 0 |
| 31 Dec 17 | 820 | 20 | 171 | 24 |
| 30 Sep 17 | 800 | 47 | 202 | 0 |
| 30 Jun 17 | 778 | 52 | 198 | 0 |
| 31 Mar 17 | 763 | 55 | 196 | 0 |
| 31 Dec 16 | 747 | 61 | 196 | 0 |
| 30 Sep 16 | 739 | 55 | 195 | 0 |
| 30 Jun 16 | 737 | 53 | 197 | 0 |
| 31 Mar 16 | 734 | 53 | 196 | 0 |
| 31 Dec 15 | 738 | 51 | 196 | 0 |
| 30 Sep 15 | 748 | 52 | 198 | 0 |
| 30 Jun 15 | 758 | 53 | 197 | 0 |
Ingresos de calidad: KWR tiene una única gran pérdida de $134.4M que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2026.
Margen de beneficios creciente: Los actuales márgenes de beneficio(0.2%) de KWR son inferiores a los del año pasado (5.2%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de KWR han disminuido en un 24.6% al año en los últimos 5 años.
Acelerando crecimiento: KWR ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: KWR tuvo un crecimiento negativo de los beneficios (-95.5%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (0.1%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de KWR (0.3%) se considera baja.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/01 23:21 |
| Precio de las acciones al final del día | 2026/05/01 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Quaker Chemical Corporation está cubierta por 13 analistas. 5 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Michael Gaugler | Brean Capital Historical (Janney Montgomery) |
| Liam Burke | B. Riley Securities, Inc. |
| Jonathan Tanwanteng | CJS Securities, Inc. |